AMARIN CORP PLC\UK Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
AMARIN CORP PLC\UK (AMRN) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.04% for the 12-month period ending 2014-12-31, per its 10-Q filed 2015-05-08.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2015-11-04
- AMARIN CORP PLC\UK fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 0.07%, a 65.00% decline year-over-year.
- AMARIN CORP PLC\UK fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 0.20%.
- AMARIN CORP PLC\UK fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 0.12%, a 52.00% decline from fiscal 2012.
- AMARIN CORP PLC\UK fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 0.25%, a 30.56% decline from fiscal 2011.
- AMARIN CORP PLC\UK fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2011 was 0.36%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 1 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2014-12-31 | 0.04% 10-Q · filed 2015-11-04 | 0.04% 10-Q · filed 2015-05-08 | ||||
| 2014-09-30 | 0.02% 10-Q · filed 2014-11-06 | |||||
| 2014-06-30 | 0.04% 10-Q · filed 2014-08-07 | |||||
| 2014-03-31 | 0.07% 10-Q · filed 2014-05-09 | |||||
| 2013-12-31 | 0.12% 10-K · filed 2015-03-03 | |||||
| 2013-09-30 | 0.10% 10-Q · filed 2013-11-07 | |||||
| 2013-06-30 | 0.20% 10-Q · filed 2013-08-08 | |||||
| 2013-03-31 | 0.20% 10-Q · filed 2013-05-09 | |||||
| 2012-12-31 | 0.25% 10-K · filed 2014-02-27 | |||||
| 2012-09-30 | 0.23% 10-Q · filed 2012-11-08 | |||||
| 2012-06-30 | 0.35% 10-Q · filed 2012-08-08 | |||||
| 2011-12-31 | 0.36% 10-K · filed 2013-02-28 | |||||
| 2009-10-31 | 2.37% 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |